We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Plans to Update Guidance on Trials for Cancer Drugs
EMA Plans to Update Guidance on Trials for Cancer Drugs
September 29, 2010
Noting that roughly a third of new chemical and biological entities in clinical development are anti-cancer treatments, the European Medicines Agency (EMA) may update its guideline on trials for anti-cancer drugs.